BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sacramento CB, Sondhi D, Rosenberg JB, Chen A, Giordano S, Pey E, Lee V, Stiles KM, Havlicek DF, Leopold PL, Kaminsky SM, Crystal RG. Anti-Phospho-Tau Gene Therapy for Chronic Traumatic Encephalopathy. Hum Gene Ther 2020;31:57-69. [PMID: 31608704 DOI: 10.1089/hum.2019.174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Roberta de Souza Mendes Kawamura L, Ferreira Lima Mota I, Santos Vasconcelos A, Renata Mortari M. Challenges in the pharmacological treatment of patients under suspicion of chronic traumatic encephalopathy: A review. Brain Res 2023;1799:148176. [PMID: 36503890 DOI: 10.1016/j.brainres.2022.148176] [Reference Citation Analysis]
2 Mahamane Salissou MT, Razak MYA, Wang X, Magaji RA. The role of protein phosphatase 2A tau axis in traumatic brain injury therapy. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00223-1] [Reference Citation Analysis]
3 Bajracharya R, Caruso AC, Vella LJ, Nisbet RM. Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain. Pharmaceutics 2021;13:2014. [PMID: 34959296 DOI: 10.3390/pharmaceutics13122014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Kahriman A, Bouley J, Smith TW, Bosco DA, Woerman AL, Henninger N. Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: characterization of a novel model and systematic review of the literature. Acta Neuropathol Commun 2021;9:118. [PMID: 34187585 DOI: 10.1186/s40478-021-01220-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 Pierre K, Dyson K, Dagra A, Williams E, Porche K, Lucke-Wold B. Chronic Traumatic Encephalopathy: Update on Current Clinical Diagnosis and Management. Biomedicines 2021;9:415. [PMID: 33921385 DOI: 10.3390/biomedicines9040415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Huang RY, Liu ZH, Weng WH, Chang CW. Magnetic nanocomplexes for gene delivery applications. J Mater Chem B 2021;9:4267-86. [PMID: 33942822 DOI: 10.1039/d0tb02713h] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
7 Crystal RG. My Pathway to Gene Therapy. Human Gene Therapy 2020;31:273-282. [DOI: 10.1089/hum.2020.29112.rgc] [Reference Citation Analysis]
8 Flotte TR. Gene Therapy Untangles the Problem of Chronic Traumatic Encephalopathy. Human Gene Therapy 2020;31:12-13. [DOI: 10.1089/hum.2019.29104.trf] [Reference Citation Analysis]